ATTORNEY ADVERTISEMENT. Samuel L. Eilers, Esq. (CA SBN 289222), 3099 Driscoll Drive, San Diego, CA 92117
Advertising by a legal marketing service. No attorney-client relationship is formed.
Ozempic / GLP-1 Lawsuit
GLP-1 drugs including Ozempic, Wegovy, and Mounjaro face claims for gastroparesis, intestinal obstruction, and vision issues.
Intake criteria and litigation status are summarized below.
Results vary. Past results do not guarantee future outcomes. No compensation is guaranteed.
Symptoms & Injuries
- Gastroparesis
- Intestinal blockage
- Persistent vomiting
- NAION / vision loss
Intake Criteria
- • Used Ozempic, Wegovy, Mounjaro, or similar
- • Hospitalization or severe GI injury
- • Injury after starting medication
Lawsuit Updates
2024
MDL formation under review
Federal courts evaluating consolidation of GLP-1 injury claims.
MDL Information
- Court
- Pending consolidation
- Docket
- Emerging MDL
- Filed
- 2024
- Overview
- Growing litigation over GLP-1 adverse events.
FAQ
Relevant information may include Ozempic use or exposure, related injuries, usage duration, diagnosis, and state-specific deadlines.